Following an invitation from Greek authorities, a team of experts from the ECDC Programme for HIV/AIDS, Sexually Transmitted and Blood-borne infections, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the WHO Regional Office for Europe will visit Greece on 28 and 29 May 2012. The European Union Agency for Fundamental Rights (FRA) will join the mission as observers.
In an expert meeting in Stockholm, identified synergies and gaps in the availability of sexual health data, programmes, initiatives and policies across Europe and possibilities for future work will be discussed.
Adjustments to surveillance practices in the EU will enhance preparedness and public health response to emerging infectious diseases, thereby helping to contain human and economic costs. These are the conclusions of an article published this week in Science magazine, describing a study co-authored by ECDC.
Since November 2011, Schmallenberg virus has been reported in cattle, sheep and goats in Germany, the Netherlands, Belgium, the United Kingdom, France, Luxembourg, Italy and more recently in Spain.
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published the second joint EU report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and food.
Since November 2011, Schmallenberg virus has been reported in cattle, sheep and goats in Germany, the Netherlands, Belgium, the United Kingdom, France, Luxembourg, Italy and more recently in Spain.
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published their annual report on zoonoses and food-borne outbreaks in the European Union for 2010.
A meeting and a workshop on the ECDC point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use in acute care hospitals took take place in London on 5-6 March 2012.